Exclusive

Publication

Byline

Location

Govt lab retest confirms presence of polio-2 in Bio-Med's samples

NEW DELHI, March 19 -- A government laboratory has confirmed the presence of polio-2 virus, a strain that was believed to have been eradicated from India in 2016, in oral vaccine samples made by Bio-M... Read More


Govt lab retest confirms presence of polio-2 in Bio-Med's samples

NEW DELHI, March 19 -- A government laboratory has confirmed the presence of polio-2 virus, a strain that was believed to have been eradicated from India in 2016, in oral vaccine samples made by Bio-M... Read More


Govt lab retest confirms polio strain's presence in Bio-Med samples

New Delhi, March 19 -- A government laboratory has confirmed the presence of polio-2 virus, a strain that was believed to have been eradicated from India in 2016, in oral vaccine samples made by Bio-M... Read More


SC asks Singh bros to submit plan to pay Rs 3,500 crore

MUMBAI, March 15 -- The Supreme Court on Thursday directed estranged brothers and former promoters of Ranbaxy Laboratories Ltd, Malvinder and Shivinder Singh, to come up with a plan to secure the Rs 3... Read More


SC asks Singh bros to submit plan to pay Rs3,500 crore

MUMBAI, March 15 -- The Supreme Court on Thursday directed estranged brothers and former promoters of Ranbaxy Laboratories Ltd, Malvinder and Shivinder Singh, to come up with a plan to secure the Rs3,... Read More


Daiichi-Ranbaxy arbitration case: Find a way to pay up, SC tells Singh brothers

New Delhi, March 15 -- The Supreme Court on Thursday directed Singh brothers Malvinder and Shivinder, the former promoters of Ranbaxy Laboratories, to come up with a plan to secure the Rs.3,500 crore ... Read More


SC to hear Daiichi plea on arbitration case against Singh brothers on Thursday

New Delhi, March 13 -- The crucial hearing on Rs.3,500 crore arbitration case against former Ranbaxy Ltd promoters Malvinder and Shivinder Singh and Japanese drug makrer Daiichi Sankyo Inc, which is s... Read More


Regulator tells J&J to pay Rs.75 lakh in faulty hip implant case

New Delhi, March 11 -- In a major breakthrough for patients in the Johnson and Johnson Pvt. Ltd's faulty hip implants case, India's drug regulator has ordered the company to pay Rs.74.6 lakh to an uni... Read More


MRPs of 390 cancer medicines cut by 87% after price control order

New Delhi, March 8 -- The maximum retail price (MRP) of 390 non-scheduled cancer medicines have been reduced by up to 87%, the government said Friday, days after India's drug pricing regulator brought... Read More


Guru used part of Ranbaxy sale money on realty, says Malvinder

New Delhi, March 8 -- Businessman Malvinder Singh has alleged that part of the proceeds from the stake sale in Ranbaxy Laboratories Ltd was used by Gurinder Singh Dhillon, the spiritual head of Radha ... Read More